Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-hour versus 24-hour magnesium sulfate treatment in preeclampsia
IRCT20200503047287N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of magnesium sulfate in preeclampsia (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Systolic blood pressure before intervention, Diastolic blood pressure before intervention and 10 more. Started Sep 2020; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20200503047287N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200503047287N1.